Director, US TUKYSA HCP Marketing Lead

Join us to make history — for patients, for their families, for the future. At Pfizer Oncology, our mission is to "Outdo Cancer" by developing transformative therapies that make a meaningful impact for patients. Pfizer Oncology currently boasts an industry-leading portfolio spanning breast as well as genitourinary (GU) cancers, hematology-oncology, gastrointestinal-oncology, and thoracic cancers. The US Breast Cancer Business is one of the largest businesses within Pfizer Oncology.

It is anchored by a multibillion-dollar asset IBRANCE, as well as TUKYSA in metastatic breast cancer, and a robust pipeline of breast cancer innovation.

Pfizer Commercial Oncology is introducing the world to the next era of cancer care. With a growing portfolio of novel therapies, industry-leading R&D, and a goal of delivering eight breakthroughs by 2030 across major cancer types, we're translating cutting-edge science into market-shaping impact. Here, you'll partner with exceptional colleagues across scientific, medical, and manufacturing teams, backed by advanced digital and AI-enabled infrastructure and the authority to accelerate medicines from discovery to delivery.

Guided by our values of courage, excellence, equity, and joy, you'll have the opportunity to stretch your skills and build a career that evolves with you — across teams, roles, and the Pfizer enterprise. Join us to make history — for patients, for their families, for the future. At Pfizer Oncology, our mission is to "Outdo Cancer" by developing transformative therapies that make a meaningful impact for patients.

Pfizer Oncology currently boasts an industry-leading portfolio spanning breast as well as genitourinary (GU) cancers, hematology-oncology, gastrointestinal-oncology, and thoracic cancers. The US Breast Cancer Business is one of the largest businesses within Pfizer Oncology.

It is anchored by a multibillion-dollar asset IBRANCE, as well as TUKYSA in metastatic breast cancer, and a robust pipeline of breast cancer innovation. TUKYSA is entering one of the most consequential windows in the brand's history with the anticipated launch of the HER2

CLIMB-05 first-line maintenance (1

Lm) indication in human epidermal growth factor receptor 2-positive (HER2+) metastatic breast cancer (mBC, PDUFA Oct 17, 2026). HER2

CLIMB-05 marks a new era for the Pfizer Breast Cancer Franchise, with TUKYSA poised as the franchise growth driver. TUKYSA is also indicated for HER2+ metastatic colorectal cancer (mCRC). Over the next years, several pivotal trial readouts are anticipated across both mBC and mCRC for TUKYSA. The HCP Marketing Lead is a critical strategic and operational leadership role. Operating as an individual contributor in a highly matrixed environment, the Director is the strategic architect of TUKYSA HCP marketing, owning positioning, value proposition, core claims and messaging architecture.

The role leads the HCP agency partnership and serves as the primary Marketing partner to Sales for personal promotion, ensuring strategy translates into effective field execution. The Director, US TUKYSA HCP Marketing Lead will report to the Sr. Director, US TUKYSA Lead and be part of a mission-driven, innovative, and talented team of diverse colleagues, partnering closely with Sales, Insights & Analytics, Medical, Regulatory, Legal and other cross-functional partners.

• Set and evolve the HCP marketing strategy through launch and beyond, translating emerging customer, competitive and performance dynamics into strategic, executional and investment decisions.
• Define TUKYSA HCP positioning, value proposition, messaging and claims architecture, ensuring compelling competitive differentiation as the market evolves.
• Establish HCP…